Details for Patent: 7,622,470
✉ Email this page to a colleague
Which drugs does patent 7,622,470 protect, and when does it expire?
Patent 7,622,470 protects FOLOTYN and is included in one NDA.
This patent has thirty-one patent family members in twenty-three countries.
Summary for Patent: 7,622,470
| Title: | Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| Abstract: | T cell lymphoma is treated by administering to a patient suffering from T cell lymphoma a therapeutically effective amount of 10-propargyl-10-deazaaminopterin. Remission is observed in human patients, even with drug resistant T cell lymphoma at weekly dosages levels as low as 30 mg/m.sup.2. In general, the 10-propargyl-10-deazaaminopterin is administered in an amount of from 30 to 275 mg/m.sup.2 per dose. |
| Inventor(s): | O'Connor; Owen A. (Scarsdale, NY), Sirotnak; Francis M. (Hampton Bays, NY) |
| Assignee: | Sloan-Kettering Institute for Cancer Research (New York, NY) |
| Application Number: | 11/141,868 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,622,470 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 7,622,470
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acrotech Biopharma | FOLOTYN | pralatrexate | SOLUTION;INTRAVENOUS | 022468-001 | Sep 24, 2009 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA | ⤷ Sign Up | ||||
| Acrotech Biopharma | FOLOTYN | pralatrexate | SOLUTION;INTRAVENOUS | 022468-002 | Sep 24, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,622,470
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | E405272 | ⤷ Sign Up | |||
| Australia | 2005249516 | ⤷ Sign Up | |||
| Brazil | PI0510895 | ⤷ Sign Up | |||
| Canada | 2565968 | ⤷ Sign Up | |||
| China | 102824346 | ⤷ Sign Up | |||
| China | 1960734 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
